199 related articles for article (PubMed ID: 21930711)
21. A MID1 gene mutation in a patient with Opitz G/BBB syndrome that altered the 3D structure of SPRY domain.
Hu CH; Liu YF; Yu JS; Ng YY; Chen SJ; Su PH; Chen JY
Am J Med Genet A; 2012 Apr; 158A(4):726-31. PubMed ID: 22407675
[TBL] [Abstract][Full Text] [Related]
22. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
23. XLOS-observed mutations of MID1 Bbox1 domain cause domain unfolding.
Wright KM; Wu K; Babatunde O; Du H; Massiah MA
PLoS One; 2014; 9(9):e107537. PubMed ID: 25216264
[TBL] [Abstract][Full Text] [Related]
24. Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G/BBB syndrome.
Kruszka P; Li D; Harr MH; Wilson NR; Swarr D; McCormick EM; Chiavacci RM; Li M; Martinez AF; Hart RA; McDonald-McGinn DM; Deardorff MA; Falk MJ; Allanson JE; Hudson C; Johnson JP; Saadi I; Hakonarson H; Muenke M; Zackai EH
J Med Genet; 2015 Feb; 52(2):104-10. PubMed ID: 25412741
[TBL] [Abstract][Full Text] [Related]
25. Hypospadias associated with hypertelorism, the mildest phenotype of Opitz syndrome.
Zhang X; Chen Y; Zhao S; Markljung E; Nordenskjöld A
J Hum Genet; 2011 May; 56(5):348-51. PubMed ID: 21326312
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular studies of patients with characteristics of Opitz G/BBB syndrome shows a novel MID1 mutation.
Hsieh EW; Vargervik K; Slavotinek AM
Am J Med Genet A; 2008 Sep; 146A(18):2337-45. PubMed ID: 18697196
[TBL] [Abstract][Full Text] [Related]
27. The MID1 protein is a central player during development and in disease.
Winter J; Basilicata MF; Stemmler MP; Krauss S
Front Biosci (Landmark Ed); 2016 Jan; 21(3):664-82. PubMed ID: 26709798
[TBL] [Abstract][Full Text] [Related]
28. R368X mutation in MID1 among recurrent mutations in patients with X-linked Opitz G/BBB syndrome.
Preiksaitiene E; Krasovskaja N; Utkus A; Kasnauskiene J; Meškienė R; Paulauskiene I; Valevičienė NR; Kučinskas V
Clin Dysmorphol; 2015 Jan; 24(1):7-12. PubMed ID: 25304119
[TBL] [Abstract][Full Text] [Related]
29. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22.
Quaderi NA; Schweiger S; Gaudenz K; Franco B; Rugarli EI; Berger W; Feldman GJ; Volta M; Andolfi G; Gilgenkrantz S; Marion RW; Hennekam RC; Opitz JM; Muenke M; Ropers HH; Ballabio A
Nat Genet; 1997 Nov; 17(3):285-91. PubMed ID: 9354791
[TBL] [Abstract][Full Text] [Related]
30. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
[TBL] [Abstract][Full Text] [Related]
31. Absence of the RING domain in
Frank S; Gabassi E; Käseberg S; Bertin M; Zografidou L; Pfeiffer D; Brennenstuhl H; Falk S; Karow M; Schweiger S
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38238086
[TBL] [Abstract][Full Text] [Related]
32. Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.
Winter J; Kunath M; Roepcke S; Krause S; Schneider R; Schweiger S
BMC Mol Biol; 2007 Nov; 8():105. PubMed ID: 18005432
[TBL] [Abstract][Full Text] [Related]
33. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
[TBL] [Abstract][Full Text] [Related]
34. MID1 mutations in patients with X-linked Opitz G/BBB syndrome.
Fontanella B; Russolillo G; Meroni G
Hum Mutat; 2008 May; 29(5):584-94. PubMed ID: 18360914
[TBL] [Abstract][Full Text] [Related]
35. MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified.
Ferrentino R; Bassi MT; Chitayat D; Tabolacci E; Meroni G
Hum Mutat; 2007 Feb; 28(2):206-7. PubMed ID: 17221865
[TBL] [Abstract][Full Text] [Related]
36. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination.
McConnell JL; Watkins GR; Soss SE; Franz HS; McCorvey LR; Spiller BW; Chazin WJ; Wadzinski BE
Biochemistry; 2010 Mar; 49(8):1713-8. PubMed ID: 20092282
[TBL] [Abstract][Full Text] [Related]
37. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.
Short KM; Hopwood B; Yi Z; Cox TC
BMC Cell Biol; 2002; 3():1. PubMed ID: 11806752
[TBL] [Abstract][Full Text] [Related]
38. The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.
Schweiger S; Schneider R
Bioessays; 2003 Apr; 25(4):356-66. PubMed ID: 12655643
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
Unterbruner K; Matthes F; Schilling J; Nalavade R; Weber S; Winter J; Krauß S
PLoS One; 2018; 13(1):e0190437. PubMed ID: 29293623
[TBL] [Abstract][Full Text] [Related]
40. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations.
So J; Suckow V; Kijas Z; Kalscheuer V; Moser B; Winter J; Baars M; Firth H; Lunt P; Hamel B; Meinecke P; Moraine C; Odent S; Schinzel A; van der Smagt JJ; Devriendt K; Albrecht B; Gillessen-Kaesbach G; van der Burgt I; Petrij F; Faivre L; McGaughran J; McKenzie F; Opitz JM; Cox T; Schweiger S
Am J Med Genet A; 2005 Jan; 132A(1):1-7. PubMed ID: 15558842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
